AGP Picks
View all

Mining Press Releases
Provided by AGP

Mining Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mining Press Releases.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on September 28, 2026

ASML reports transactions under its current share buyback program
Sep. 28, 2026

ASML reports transactions under its current share buyback program

Indeterminate GlobeNewswire
KNKA Previews the 2500 Pet Air Purifier Ahead of October 1 Launch, Highlighting Pet Mode for Owner-Away Hours
Sep. 28, 2026

KNKA Previews the 2500 Pet Air Purifier Ahead of October 1 Launch, Highlighting Pet Mode for Owner-Away Hours

Indeterminate GlobeNewswire
Lucasys Announces The Gathering, Its Inaugural Customer Conference
Sep. 28, 2026

Lucasys Announces The Gathering, Its Inaugural Customer Conference

Indeterminate GlobeNewswire
Adhesion Wealth Launches Custom Model Solutions for RIAs
Sep. 28, 2026

Adhesion Wealth Launches Custom Model Solutions for RIAs

Indeterminate GlobeNewswire
Kaltura Wins Best Interactive Content Platform in the 2026 Digiday Technology Awards
Sep. 28, 2026

Kaltura Wins Best Interactive Content Platform in the 2026 Digiday Technology Awards

Indeterminate GlobeNewswire
COMSTOCK ANNOUNCES SIGNING OF FRAMEWORK AGREEMENT FOR $1.65 BILLION STRATEGIC PARTNERSHIP WITH SOCAR
Sep. 28, 2026

COMSTOCK ANNOUNCES SIGNING OF FRAMEWORK AGREEMENT FOR $1.65 BILLION STRATEGIC PARTNERSHIP WITH SOCAR

Indeterminate GlobeNewswire
Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD
Sep. 28, 2026

Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD

Indeterminate GlobeNewswire
GuideAI Health Corp. and vRad Renew Data Exclusivity Agreement to Develop AI Models for the Detection and Characterization of Multiple Vascular Diseases
Sep. 28, 2026

GuideAI Health Corp. and vRad Renew Data Exclusivity Agreement to Develop AI Models for the Detection and Characterization of Multiple Vascular Diseases

Indeterminate GlobeNewswire
ROC Secures $64.3 Million U.S. Department of Justice Contract for Digital Evidence Technology
Sep. 28, 2026

ROC Secures $64.3 Million U.S. Department of Justice Contract for Digital Evidence Technology

Indeterminate GlobeNewswire
NETSOL Technologies reports record fiscal 2026 revenue and full-year profitability, exceeding guidance
Sep. 28, 2026

NETSOL Technologies reports record fiscal 2026 revenue and full-year profitability, exceeding guidance

Indeterminate GlobeNewswire
Curonix Announces Published PNS IMPACT Clinical Study Showing Freedom® Peripheral Nerve Stimulator (PNS) System is Associated with Reductions in Pain Scores, Opioid Use and Overall Patient Burden
Sep. 28, 2026

Curonix Announces Published PNS IMPACT Clinical Study Showing Freedom® Peripheral Nerve Stimulator (PNS) System is Associated with Reductions in Pain Scores, Opioid Use and Overall Patient Burden

Indeterminate GlobeNewswire
Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer
Sep. 28, 2026

Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer

Indeterminate GlobeNewswire
Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik
Sep. 28, 2026

Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik

Indeterminate GlobeNewswire
4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME
Sep. 28, 2026

4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME

Indeterminate GlobeNewswire
Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4
Sep. 28, 2026

Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4

Indeterminate GlobeNewswire
Core Molding Technologies Promotes Michael J. Gayford to Chief Operating Officer
Sep. 28, 2026

Core Molding Technologies Promotes Michael J. Gayford to Chief Operating Officer

Indeterminate GlobeNewswire
ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
Sep. 28, 2026

ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer

Indeterminate GlobeNewswire
icMercury Selected for In-Orbit Validation Mission Aboard PocketQube Satellite on SpaceX Transporter-18
Sep. 28, 2026

icMercury Selected for In-Orbit Validation Mission Aboard PocketQube Satellite on SpaceX Transporter-18

Indeterminate GlobeNewswire
Newtek Bank Expands Connected Banking Capabilities Across Leading Accounting and Business Applications
Sep. 28, 2026

Newtek Bank Expands Connected Banking Capabilities Across Leading Accounting and Business Applications

Indeterminate GlobeNewswire
NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes
Sep. 28, 2026

NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Mining Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.